About the Pivot Park Screening Centre
The Pivot Park Screening Centre (PPSC) provides its customers and partners the best confirmed leads for development of new medicines.
At the basis are our state-of-the-art automation - two fully automated robotic systems - and our team which has more than two decades of proven experience in High Throughput Screening (HTS). We offer tailor-made and efficient assay development followed by (ultra) HTS and profiling services. Screening can be performed on both our own library, consisting of 300.000 high quality drug-like compounds, and client libraries up to 2.5 million compounds. Optionally, libraries can be shared between clients to gain access to a larger chemical space.
Open innovation is embedded in our organisation. Our industrial pharma capabilities have been recognized by the European Community who has chosen us as the central screening site for the European Lead factory. Pivot Park Screening Centre is also partner in several other collaboration projects, all based on open innovation.
We work with our customers on a basis of open communication and trust. Our extensive drug discovery experience is shown in our efficient workflows and the necessary flexibility to provide our customers with the best confirmed leads for their target.
PPSC builds on the long-established history of pharmaceutical research in Oss, the Netherlands. The Dutch pharmaceutical company Organon was established in Oss in 1923 and developed into a successful international business. Subsequent reorganisation and re-structuring of the company saw the research labs in Oss, the Netherlands, close, but the decision was made to ensure the availability of state-of-the-art research facilities in a new life sciences park and our basis: Pivot Park.
Read our brochure for more information.